Jacobs Levy Equity Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.56M | Sell |
805,305
-166,852
| -17% | -$1.36M | 0.03% | 379 |
|
|
2025
Q1 | $7.63M | Buy |
972,157
+506,853
| +109% | +$3.98M | 0.03% | 382 |
|
|
2024
Q4 | $6.93M | Buy |
+465,304
| New | +$6.93M | 0.02% | 366 |
|
|
2024
Q3 | – | Sell |
-23,608
| Closed | -$360K | – | 1032 |
|
|
2024
Q2 | $360K | Buy |
+23,608
| New | +$360K | ﹤0.01% | 875 |
|
|
2024
Q1 | – | Sell |
-262,811
| Closed | -$5.02M | – | 1036 |
|
|
2023
Q4 | $5.02M | Buy |
262,811
+123,752
| +89% | +$2.36M | 0.03% | 425 |
|
|
2023
Q3 | $2.5M | Buy |
+139,059
| New | +$2.5M | 0.01% | 523 |
|
|
2020
Q2 | – | Sell |
-22,195
| Closed | -$308K | – | 1136 |
|
|
2020
Q1 | $308K | Sell |
22,195
-56,508
| -72% | -$784K | ﹤0.01% | 822 |
|
|
2019
Q4 | $795K | Buy |
78,703
+33,556
| +74% | +$339K | 0.01% | 725 |
|
|
2019
Q3 | $411K | Buy |
45,147
+27,071
| +150% | +$246K | 0.01% | 746 |
|
|
2019
Q2 | $144K | Buy |
+18,076
| New | +$144K | ﹤0.01% | 902 |
|